Neuroprotective Effect of Several Phytochemicals and Its Potential Application in the Prevention of Neurodegenerative Diseases

Overview

Journal Geriatrics (Basel)

Specialty Geriatrics

Date 2019 Apr 27

PMID 31022822

Citations 16

Authors

Jintang Wang

Yuetao Song

Maolong Gao

Xujing Bai

Zheng Chen

Affiliations

Soon will be listed here.

Abstract

The detrimental effects of oxidative stress and chronic neuroinflammation on neuronal cell death have been implicated in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD). The nutritional neuroscience is quickly growing, and phytochemicals or phytobioactive compounds such as curcumin, resveratrol, propolis, ginsenoside, and ω-3 polyunsaturated fatty acids (PUFAs) have been extensively applied to potential therapeutic purposes for numerous neurodegenerative diseases for their anti-oxidative and anti-inflammatory effects. However, their administration as food supplements in the daily diet of the elderly is normally a voluntary and less-organized behavior, indicating the uncertainty of therapeutic effects in this sporadic population; specifically, the effective physiological dosages and the real positive effects in preserving brain health have not yet been fully elucidated. In this review, we collect several lines of evidence on these compounds, which constitute a major type of nutraceuticals and are widely integrated into the daily anti-aging caring of elderly patients, and discuss the underlying anti-oxidative and anti-inflammatory mechanisms of these phytochemicals. In conclusion, we highlight the implications of these compounds in the prevention and treatment of geriatric diseases, and of the potential supplementation procedures used as a dietary therapeutic program in clinical nursing services for patients with neurodegenerative diseases or for the elderly in certain communities, which we hope will lead to more beneficial health outcomes with respect to brain function, innate immunity, and gastrointestinal function, as well as more economic and social benefits.

Citing Articles

Neuro-Nutrition and Exercise Synergy: Exploring the Bioengineering of Cognitive Enhancement and Mental Health Optimization.

Clemente-Suarez V, Martin-Rodriguez A, Curiel-Regueros A, Rubio-Zarapuz A, Tornero-Aguilera J Bioengineering (Basel). 2025; 12(2).

PMID: 40001727 PMC: 11851474. DOI: 10.3390/bioengineering12020208.

The dietary phytochemical index and its relation to polycystic ovary syndrome: a case-control study.

Chi Y, Yue R, Lv Y, Li H, Liao W J Ovarian Res. 2024; 17(1):228.

PMID: 39550600 PMC: 11568525. DOI: 10.1186/s13048-024-01540-y.

Modulatory Effects of Phytochemicals on Gut-Brain Axis: Therapeutic Implication.

Jaberi K, Alamdari-Palangi V, Savardashtaki A, Vatankhah P, Jamialahmadi T, Tajbakhsh A Curr Dev Nutr. 2024; 8(6):103785.

PMID: 38939650 PMC: 11208951. DOI: 10.1016/j.cdnut.2024.103785.

Ethanolic Extract of Propolis and CAPE as Cardioprotective Agents against LPS and IFN-α Stressed Cardiovascular Injury.

Kurek-Gorecka A, Klosek M, Pietsz G, Balwierz R, Olczyk P, Czuba Z Nutrients. 2024; 16(5).

PMID: 38474755 PMC: 10935265. DOI: 10.3390/nu16050627.

Medicinal herbal remedies in neurodegenerative diseases: an update on antioxidant potential.

Sarkar B, Rana N, Singh C, Singh A Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5483-5511.

PMID: 38472370 DOI: 10.1007/s00210-024-03027-5.

References

Lauritzen L, Hansen H, Jorgensen M, Michaelsen K . The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001; 40(1-2):1-94. DOI: 10.1016/s0163-7827(00)00017-5. View

Lim G, Chu T, Yang F, BEECH W, Frautschy S, Cole G . The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001; 21(21):8370-7. PMC: 6762797. View

Frautschy S, Hu W, Kim P, Miller S, Chu T, Harris-White M . Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging. 2002; 22(6):993-1005. DOI: 10.1016/s0197-4580(01)00300-1. View

Son S, Lewis B . Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J Agric Food Chem. 2002; 50(3):468-72. DOI: 10.1021/jf010830b. View

Scapagnini G, Foresti R, Calabrese V, Stella A, Green C, Motterlini R . Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol. 2002; 61(3):554-61. DOI: 10.1124/mol.61.3.554. View

Heude B, Ducimetiere P, Berr C . Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. Am J Clin Nutr. 2003; 77(4):803-8. DOI: 10.1093/ajcn/77.4.803. View

Van Kampen J, Robertson H, Hagg T, Drobitch R . Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp Neurol. 2003; 184(1):521-9. DOI: 10.1016/j.expneurol.2003.08.002. View

Kwon Y, Park D, Shin E, Kwon M, Ko K, Kim W . Antioxidant propolis attenuates kainate-induced neurotoxicity via adenosine A1 receptor modulation in the rat. Neurosci Lett. 2004; 355(3):231-5. DOI: 10.1016/j.neulet.2003.10.075. View

Han Y, Zheng W, Bastianetto S, Chabot J, Quirion R . Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol. 2004; 141(6):997-1005. PMC: 1574264. DOI: 10.1038/sj.bjp.0705688. View

10.

Wassall S, Brzustowicz M, Shaikh S, Cherezov V, Caffrey M, Stillwell W . Order from disorder, corralling cholesterol with chaotic lipids. The role of polyunsaturated lipids in membrane raft formation. Chem Phys Lipids. 2004; 132(1):79-88. DOI: 10.1016/j.chemphyslip.2004.09.007. View

11.

Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O . Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr. 2005; 135(3):549-55. DOI: 10.1093/jn/135.3.549. View

12.

Noelker C, Bacher M, Gocke P, Wei X, Klockgether T, Du Y . The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity. Neurosci Lett. 2005; 383(1-2):39-43. DOI: 10.1016/j.neulet.2005.04.023. View

13.

Calon F, Lim G, Morihara T, Yang F, Ubeda O, Salem Jr N . Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci. 2005; 22(3):617-26. DOI: 10.1111/j.1460-9568.2005.04253.x. View

14.

Stromberg I, Gemma C, Vila J, Bickford P . Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system. Exp Neurol. 2005; 196(2):298-307. DOI: 10.1016/j.expneurol.2005.08.013. View

15.

Lao C, Ruffin 4th M, Normolle D, Heath D, Murray S, Bailey J . Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006; 6:10. PMC: 1434783. DOI: 10.1186/1472-6882-6-10. View

16.

Baur J, Sinclair D . Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5(6):493-506. DOI: 10.1038/nrd2060. View

17.

Ng T, Chiam P, Lee T, Chua H, Lim L, Kua E . Curry consumption and cognitive function in the elderly. Am J Epidemiol. 2006; 164(9):898-906. DOI: 10.1093/aje/kwj267. View

18.

Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y . Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res. 2006; 56(2):159-64. DOI: 10.1016/j.neures.2006.06.010. View

19.

Schaefer E, Bongard V, Beiser A, Lamon-Fava S, Robins S, Au R . Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006; 63(11):1545-50. DOI: 10.1001/archneur.63.11.1545. View

20.

Green K, Martinez-Coria H, Khashwji H, Hall E, Yurko-Mauro K, Ellis L . Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci. 2007; 27(16):4385-95. PMC: 6672302. DOI: 10.1523/JNEUROSCI.0055-07.2007. View